Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/12591992

J. Natl. Cancer Inst. 2003 Feb 19 95 4 332; author reply 333-4

Download in:

View as

General Info

PMID
12591992